PRO DEX Inc balance sheet
At the end of fiscal 2026, PRO DEX Inc had total assets of $74.5m, total liabilities of $26.9m and shareholders' equity of $47.6m. It held $8.2m in cash against $21.7m of debt: net debt of $13.5m.
Balance sheet
| Fiscal year | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5 | 4 | 2 | 3 | 1 | 2 | 4 | 5 | 8 | 6 | 4 | 1 | 3 | 3 | 0 | 8 | 12 |
| Receivables | 3 | 2 | 1 | 2 | 2 | 1 | 4 | 3 | 4 | 5 | 11 | 15 | 10 | 14 | 16 | 21 | 18 |
| Inventory | 4 | 3 | 4 | 3 | 4 | 3 | 3 | 4 | 6 | 8 | 8 | 13 | 16 | 15 | 22 | 21 | 22 |
| Total current assets | 12 | 9 | 7 | 9 | 8 | 9 | 12 | 16 | 21 | 23 | 25 | 31 | 31 | 37 | 47 | 53 | 54 |
| Goodwill | — | — | — | — | 0 | 0 | 0 | — | — | — | — | — | — | — | — | 7 | 7 |
| Total assets | 16 | 13 | 11 | 12 | 13 | 11 | 16 | 20 | 26 | 31 | 40 | 49 | 52 | 52 | 61 | 75 | 77 |
| Accounts payable | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 2 | 5 | 5 | 4 | 5 |
| Deferred revenue (current) | — | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total current liabilities | 4 | 3 | 2 | 2 | 4 | 2 | 3 | 2 | 4 | 5 | 6 | 11 | 10 | 13 | 15 | 13 | 13 |
| Long-term debt | 1 | 0 | — | — | 0 | 0 | 0 | 0 | 5 | 4 | 13 | 14 | 13 | 12 | 15 | 18 | 12 |
| Total debt | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 | 14 | 17 | 17 | 16 | 22 | 22 | 16 |
| Total liabilities | 5 | 3 | 3 | 2 | 4 | 2 | 3 | 3 | 3 | 12 | 20 | 24 | 20 | 22 | 25 | 27 | 27 |
| Shareholders' equity | 10 | 10 | 8 | 9 | 8 | 9 | 14 | 17 | 17 | 19 | 21 | 25 | 32 | 31 | 37 | 48 | 49 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | — | — | 5 | — | −1 | — | — | — | — | — | — |
| Net debt (negative = net cash) | −3 | −4 | −1 | −3 | −1 | −2 | −4 | −5 | −3 | −2 | 10 | 16 | 14 | 14 | 21 | 14 | 5 |
| Shares outstanding | 3m | 3m | 3m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 3m | 3m | 3m | 3m |
| Quarter | 2025 Q2Dec 2024 | 2025 Q3Mar 2025 | 2025 Q4Jun 2025 | 2026 Q1Sept 2025 | 2026 Q2Dec 2025 | 2026 Q3Mar 2026 | 2026 Q4Jun 2026 | 2027 Q1Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 18 | 16 | 16 | 18 | 18 | 19 | 21 | 18 |
| Inventory | 20 | 23 | 22 | 22 | 22 | 22 | 21 | 22 |
| Total current assets | 44 | 50 | 47 | 51 | 49 | 54 | 53 | 54 |
| Goodwill | — | — | — | — | — | 7 | 7 | 7 |
| Total assets | 60 | 64 | 61 | 64 | 62 | 75 | 75 | 77 |
| Accounts payable | 6 | 6 | 5 | 4 | 4 | 5 | 4 | 5 |
| Deferred revenue (current) | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Total current liabilities | 17 | 18 | 15 | 14 | 12 | 15 | 13 | 13 |
| Long-term debt | 10 | 10 | 15 | 9 | 8 | 14 | 18 | 12 |
| Total debt | 10 | 10 | 15 | 9 | 8 | 14 | 18 | 12 |
| Total liabilities | 29 | 29 | 25 | 23 | 21 | 30 | 27 | 27 |
| Shareholders' equity | 32 | 35 | 37 | 42 | 42 | 45 | 48 | 49 |
| Shares outstanding | 3m | 3m | 3m | 3m | 3m | 3m | 3m | 3m |
Compare with peers
- Tela Bio, Inc. balance sheet
- Sight Sciences, Inc. balance sheet
- Avita Medical, Inc. balance sheet
- Electromed, Inc. balance sheet
- Pulmonx Corp balance sheet
Head to head: PDEX vs TELAPDEX vs SGHTPDEX vs RCELELMD vs PDEX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies